2m 2m 2m 2m 2m 2m 2m
Endexx (EDXC)
OTC
$0.000001-$0.00010 (-99.00%)
Price as of Oct 21, 2026- N/AMarket Cap
- -99.96%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Endexx (EDXC)
$0.000001-$0.00010 (-99.00%)
EDXC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.00 | ||
Change | -$0.00010 (-99.00%) | ||
Open | $0.00 | ||
High | $0.00 | ||
Low | $0.00 | ||
Previous Close | $0.00 | ||
Volume | 156,411 | ||
30-Day Average Volume | 203,446 | ||
1-Week Change | -99.00% | ||
1-Month Change | -99.00% | ||
1-Year Change | -99.96% | ||
3-Year Change | -100.00% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 506.4M | ||
Total Assets | $12.2M | ||
Market Cap | N/A | ||
Enterprise Value | N/A | ||
Period: QTR TTM FY | |||
Revenue | $118,599.00 | ||
Net Income | -$1.8M | ||
Free Cash Flow | -$266,506.00 | ||
EBIT | -$1.5M | ||
EBITDA | -$1.5M | ||
Net Working Capital | -$23.1M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | -1 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -33 | ||
Price/Operating Cash Flow | -33 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||